Jennifer Panganiban, MD
Associate Professor of Clinical Pediatrics (Gastroenterology, Hepatology and Nutrition)
Medical Director, Metabolic dysfunction Associated Steatotic Liver Disease, Children's Hospital of Philadelphia
Medical Director, Nutrition Support Service, Children's Hospital of Philadelphia
Co-Director, Nutrition Fellowship, Children's Hospital of Philadelphia
Director Nutrition Fellowship, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of GI, Hepatology and Nutrition
34th and Civic Center Boulevard
Philadelphia, PA 19104
Division of GI, Hepatology and Nutrition
34th and Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-590-3630
Fax: 215-590-3606
Fax: 215-590-3606
Email:
panganibaj@chop.edu
panganibaj@chop.edu
Links
International NASH day 2021
NAFLD program page
International NASH Day Press
NAFLD PAGE
NASPGHAN Webinar on MASLD
Healio coverage on GLP 1 RA work on Pediatric MASLD
International NASH day 2021
NAFLD program page
International NASH Day Press
NAFLD PAGE
NASPGHAN Webinar on MASLD
Healio coverage on GLP 1 RA work on Pediatric MASLD
Education:
BS (Biology)
University of Santo Tomas, Manila, Philippines, 2001.
MD
University of Santo Tomas, Manila, Philippines, 2005.
Permanent linkBS (Biology)
University of Santo Tomas, Manila, Philippines, 2001.
MD
University of Santo Tomas, Manila, Philippines, 2005.
Description of Clinical Expertise
https://www.chop.edu/centers-programs/non-alcoholic-fatty-liver-disease-clinichttps://www.chop.edu/conditions-diseases/non-alcoholic-fatty-liver-disease-nafld
https://www.chop.edu/news/childrens-hospital-philadelphia-celebrates-nashday
Description of Research Expertise
Introduction to Pediatric NAFLD Series - Panganiban - 2021 - Clinical Liver Disease - Wiley Online Library https://doi.org/10.1002/cld.1036Selected Publications
Yu EL, You H, Rudolph B, Panganiban, J et al. : Patient perspective on exercise practices, preferences, and barriers in pediatric nonalcoholic fatty liver dis-ease: a multicenter survey. JPGN Reports 1-9, 2024.Anam Bashir, Maria Mascarenhas, Jennifer Panganiban: Parenteral Nutrition, accepted awaiting publication. Wyllie, Pediatric Gastrointestinal and Liver Disease 7th edition 2024.
Andrea Tou MD and Jennifer Panganiban MD: GLP-1 receptor agonists have a potential to improve disease activity in pediatric metabolic-dysfunction as-sociated steatotic liver disease. Gastroenterology. Oral abstract, Digestive Diseases Week 166(5), 2024.
Andrea Tou and Jennifer Panganiban: GLP-1 Receptor Agonists have a potential to improve disease activity in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease. Accepted for Oral Presentation, American Association for the Study of Liver Diseases (AASLD)Liver Meeting 2024.
Anam Bashir, Meg Begany, Lauren Karel, Jennifer Panganiban: Treatment Outcomes on High Dose Fish Oil Lipid Emulsion – A Single Center Case Series. Oral abstract, ASPEN 2024.
Amalia Berna, PhD, Audrey John, Sarah Abu- Alreesh MD and Jennifer Panganiban: Microbially derived volatile metabolites in pediatric MASLD. Poster, 10th International Human Microbiome Consortium Congress 2024.
Bashir, A, Begany, M, Karel, L. Panganiban: Treatment Outcomes with Use of Two Lipid Sources for Parenteral Nutrition in Infants. Poster, ASPEN 2024.
Sarah Abu- Alreesh MD, Amalia Berna, PhD, Audrey John and Jennifer Panganiban: Microbially derived volatile metabolites in pediatric MASLD. Accepted for Oral Abstract,North American Society For Pediatric Gastroenterology, Hepatology & Nutrition National Conference 2024.
Andrea Tou, Rima Fawaz, Emily Carr, Pamela Valentino, Ana Arce-Clachar, Marialena Mouzaki, Jennifer Panganiban, Taisa Kohut: Topiramate: A possible therapeutic option for Pediatric MASLD. Accepted for Oral abstract, North American Society For Pediatric Gastroenterology, Hepatology & Nutrition National Conference 2024.
Paul, E, Sullivan, E, Caron J, Zong, W, Panganiban : The Who, When, Why of Carnitine Supplementation in Pediatric Parenteral Nutrition. Poster, ASPEN 2024.